A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
…, SA Lother, LJ MacKenzie, G Drobot… - New England journal …, 2020 - Mass Medical Soc
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
…, SA Lother, LJ MacKenzie, G Drobot… - Annals of internal …, 2020 - acpjournals.org
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
…, SA Lother, LJ MacKenzie, G Drobot… - Open forum …, 2020 - academic.oup.com
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
[HTML][HTML] Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic …
…, AS Bangdiwala, MP Cheng, G Drobot… - Canadian Journal of …, 2020 - ncbi.nlm.nih.gov
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …
Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole
GR Drobot, JA Karlowsky, DJ Hoban… - Antimicrobial agents …, 1996 - Am Soc Microbiol
The activities of three antibiotics in both Mueller-Hinton broth (MHB) and pooled human
urine were compared by using an in vitro pharmacodynamic model. Clinical and reference …
urine were compared by using an in vitro pharmacodynamic model. Clinical and reference …
A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department
…, CM Seifer, R Steigerwald, G Drobot… - Acute Cardiac …, 2016 - Taylor & Francis
Atrial fibrillation (AF) is the most common arrhythmia and is associated with an increase in
the risk of ischemic stroke. The risk of stroke can be significantly decreased by oral …
the risk of ischemic stroke. The risk of stroke can be significantly decreased by oral …
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect
RJ Davidson, GR Drobot, JA Karlowsky… - Journal of …, 1994 - academic.oup.com
The accumulation of radiolabelled pefloxacin, norfloxacin, and lomefloxacin was determined
in Staphylococcus aureus during log phase growth, the postantibiotic effect (PAE), and at 1, …
in Staphylococcus aureus during log phase growth, the postantibiotic effect (PAE), and at 1, …
Post-exposure prophylaxis or preemptive therapy for SARS-Coronavirus-2: study protocol for a pragmatic randomized controlled trial
…, A Agostinis, AS Bangdiwala, MP Cheng, G Drobot… - medRxiv, 2020 - medrxiv.org
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in December 2019 causing the coronavirus disease 2019 (COVID-19) pandemic. Currently, …
in December 2019 causing the coronavirus disease 2019 (COVID-19) pandemic. Currently, …
Prophylaxie post-exposition ou traitement préventif pour le syndrome respiratoire aigu sévère du coronavirus 2 (SARS-CoV-2): protocole d'étude pour une étude …
…, AS Bangdiwala, MP Cheng, G Drobot… - Canadian Journal of …, 2020 - Springer
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …
in December 2019 causing the coronavirus disease (COVID-19) pandemic. Currently, there …
[PDF][PDF] Canadian Society of Internal Medicine (CSIM)/Rocky Mountain
R Herman, N Campbell, G Drobot… - Crit Care …, 2011 - evidencebasedmarketing.ca
The 2011 Page 1 1 CONFIDENTIAL - Distribution or use of this document and the contents
is prohibited without the express written permission of EBM Consulting Inc. www.…
is prohibited without the express written permission of EBM Consulting Inc. www.…
